ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Aurobindo gets USFDA nod for dexmedetomidine HCL in 0.9% sodium chloride injection
December 10, 2020Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 200 µg/50 mL and 400 µg/100 mL Single Dose flexible containers (bags).
Pharma Sources Insight January 2025
